Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23509081 | 0.96 | USP2 (0.36) | USP2CYP11B1CYP11B2CYP2D6CYP2C9 | |
| SCHEMBL357309 | 0.92 | CYP11B1 (0.37) | CYP11B1CYP11B2TSHRCYP1A2 | |
| SCHEMBL4406755 | 0.88 | USP2 (0.33) | USP2CYP3A4 | |
| SCHEMBL15962732 | 0.84 | USP2 (0.45) | USP2CYP2D6CYP2C9TSHRHSD17B10 | |
| SCHEMBL25049534 | 0.84 | USP2 (0.45) | USP2CYP2D6CYP2C9TSHRHSD17B10 | |
| SCHEMBL24713778 | 0.79 | USP2 (0.36) | USP2CYP11B1CYP11B2CYP2D6TSHR | |
| SCHEMBL15451904 | 0.79 | USP2 (0.36) | USP2CYP11B1CYP11B2CYP2D6TSHR | |
| SCHEMBL24713161 | 0.79 | USP2 (0.36) | USP2CYP11B1CYP11B2CYP2D6TSHR | |
| SCHEMBL23508665 | 0.78 | USP2 (0.40) | USP2CYP2D6CYP2C9TSHRHSD17B10 | |
| SCHEMBL14154426 | 0.78 | CYP1A2 (0.37) | CYP2D6TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021115286-A1 | SIX-MEMBERED AND FIVE-MEMBERED AROMATIC RING DERIVATIVE CONTAINING NITROGEN HETEROATOMS WHICH CAN BE USED AS SHP2 INHIBITOR | 成都倍特药业股份有限公司 | 2021-06-17 | — | — | WO | disclosed |